Burning Rock Biotech (BNR) Receivables - Net (2019 - 2025)

Burning Rock Biotech's Receivables - Net history runs 7 years deep, the most recent figure standing at $23.9 million for Q4 2025.

• In Q4 2025, Receivables - Net rose 13.0% year-over-year to $23.9 million; the TTM figure through Dec 2025 stood at $23.9 million (up 13.0% YoY), while the FY2025 annual figure was $24.3 million, down 10.53% from the prior year.
• Receivables - Net was $23.9 million for Q4 2025 at Burning Rock Biotech, down from $25.8 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $26.5 million in Q2 2025 to a low of -$2.2 million in Q2 2022.
• Historically, Receivables - Net has averaged $17.7 million across 5 years, with a median of $18.5 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Receivables - Net tumbled 117.79% in 2022, then soared 1018.02% in 2023.
• A 5-year view of Receivables - Net shows it stood at $14.4 million in 2021, then climbed by 7.21% to $15.5 million in 2022, then gained by 13.97% to $17.6 million in 2023, then grew by 20.11% to $21.2 million in 2024, then rose by 13.0% to $23.9 million in 2025.
• The last three Receivables - Net figures came in at $23.9 million (Q4 2025), $25.8 million (Q3 2025), and $26.5 million (Q2 2025), per Business Quant data.